
Expanded Portfolio of Clinically Proven Incontinence Solutions


|
|
Axonics is proud to be a Gold sponsor at IUGA.
We invite you to join our symposia to learn about our expanded portfolio of clinically proven incontinence solutions.
|
|
|
Advancing Sacral Neuromodulation with the Axonics System
Thursday, 9th December at 18:15 CET
|
|
|
Join us as we discuss the innovative Axonics Sacral Neuromodulation System, including a clinical data review and perspectives on real world experience, followed by a live Q&A with our expert panel.
|
|

Karen Noblett, MD
Chief Medical Officer, Axonics
|
|

Felicia Lane, MD
UCI Health
Irvine, CA
|
|

Bertil Blok, MD
Erasmus MC
Rotterdam, The Netherlands
|
|
|
Bulkamid: Clinical Evidence Update
Friday, 10th December at 17:45 CET
|
|
|
Join us to hear the latest Bulkamid clinical data and more about how Bulkamid is a safe, durable, and effective treatment option for your patients.
|
|

Karen Noblett, MD
Chief Medical Officer, Axonics
|
|

Professor Annette Kuhn
Womens Clinic, Switzerland
and Bern University
Bern, Switzerland
|
|

Professor Tomi Mikkola
HUS Helsinki University Hospital
Helsinki, Finland
|
|
|
Important Safety Information:
Results and experiences may vary and are unique to each patient. No promise or guarantee is made about specific results or experiences.
For more information about safety and potential risks of the Axonics System go to
www.axonics.com/isi.
For a complete listing of indications, contraindications, warnings and precautions for Bulkamid, go to
www.bulkamid.com/isi.
Caution: Federal law (USA) restricts this device to sale by, or on the order of, a physician.
© 2021 Axonics, Inc. All rights reserved.
26 Technology Drive. Irvine, CA 92618
Toll-Free: 1-877-9-AXONICS
Tel: +1-949-396-6320
|
|
|
|
|
|